ID
25762
Description
Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome AE Section
Mots-clés
Versions (1)
- 18/09/2017 18/09/2017 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
18 septembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC-ND 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
AE Section GSK Ropinirole Restless Legs Syndrome 101468
AE Section GSK Ropinirole Restless Legs Syndrome 101468
- StudyEvent: ODM
Description
Adverse Event - Please note any SERIOUS events should NOT be recorded on this page, but on the SERIOUS ADVERSE EVENT pages provided. Record any Adverse event (using standard medical terminology) observed or elicited as a result of spontaneous reporting by patient 'How are you feeling' (pre-dose) and at subsequent schedules intervals post dose: 'Since you were last asked have you felt unwell or different from usual?'
Alias
- UMLS CUI-1
- C0877248
Description
Adverse Event
Type de données
boolean
Alias
- UMLS CUI [1]
- C0877248
Description
Adverse Event: Specification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C2348235
Description
Onset Date
Type de données
date
Unités de mesure
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0574845
Description
Onset Time
Type de données
time
Unités de mesure
- 24hr:min
Alias
- UMLS CUI [1]
- C0449244
Description
End Date
Type de données
date
Unités de mesure
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0806020
Description
End Time
Type de données
time
Unités de mesure
- 24hr:min
Alias
- UMLS CUI [1]
- C1522314
Description
Adverse Event Outcome
Type de données
text
Alias
- UMLS CUI [1]
- C1705586
Description
Event Course
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Description
Number of Episodes
Type de données
float
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C4086638
Description
Intensity
Type de données
text
Description
Action Taken
Type de données
text
Alias
- UMLS CUI [1]
- C2826626
Description
Relationship
Type de données
text
Alias
- UMLS CUI [1]
- C0439849
Description
Corrective Therapy
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Description
Withdrawal due to Adverse Event
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C1519255
Description
Adverse Event Date
Type de données
date
Alias
- UMLS CUI [1]
- C2697888
Similar models
AE Section GSK Ropinirole Restless Legs Syndrome 101468
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
C4086638 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])